International IPO

WeRide Inc. (WRD) files for a $450M NASDAQ IPO, targeting the autonomous vehicle market. With a strong focus on Level 4 tech and commercial robotaxi/robobus operations, WRD aims to capture significant market share. Investors should assess its path to profitability amid intense competition and regulatory hurdles.

PicoCELA Inc. (PCLA) is set to IPO on NASDAQ, offering a unique enterprise wireless mesh networking solution. With a price band of $6.00-$8.00 and targeting $7.0M in proceeds, the company aims to disrupt factory and smart city infrastructure by reducing cabling costs significantly. Investors should assess its patented technology and market adoption trajectory.

Polyrizon Ltd. (PLRZ) targets NASDAQ Capital with a $4.00-$4.50 price band, aiming to raise $4.2M. The biotech firm develops nasal hydrogel sprays utilizing proprietary 'Capture and Contain' technology for viral and allergen protection. A niche offering with potential in respiratory health.

Gelteq Ltd (GELS), a clinical-stage biotech focused on innovative oral drug delivery, is launching its IPO on NASDAQ Capital. Offering a $5.2 million raise within a $4.00 - $5.00 price band, GELS targets enhancing drug efficacy and patient compliance for prescription and animal health markets. This IPO presents a high-growth, high-risk opportunity in a specialized biotech niche.

Septerna, Inc. (SEPN) targets the NASDAQ Global, offering novel oral small molecule GPCR therapeutics. Backed by top-tier VCs, its $18.00 price aims to raise $288M. This clinical-stage biotech presents high-risk, high-reward potential for investors seeking exposure to cutting-edge drug discovery in a vast market.

SharonAI Holdings, Inc. files an S-1 registration statement for a NASDAQ IPO. Explore its GPU AI cloud compute platform, market trends, and SWOT.

Attovia Therapeutics (NASDAQ: ATTO) debuts raising $200 Million. Discover its biparatopic antibody platform, clinical trial timelines, and SWOT analysis.

Clinical-stage biopharmaceutical company Attovia Therapeutics files for NASDAQ IPO under ticker ATTO to raise up to $200 Million. Discover its drug pipelines and target valuation.

Londian Wason files for NYSE IPO under ticker FOIL to raise $78.6 Million. Discover the price band, valuation, and battery-grade copper foil manufacturing SWOT.

Sustainable fashion pioneer Reformation prices its NYSE IPO at $15 per share. Analyze the brand's growth SWOT, retail expansion plans, and valuation metrics.